Scripps MD Anderson Cancer Center

https://www.Scripps.org/HemOncCME

 

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
S

Treatment of Metastatic Urothelial Carcinoma: Frontline Chemo, IO in 1st Line and 2nd Line Setting, Enfortumab Vedotin in Post IO Setting & Erdafitinib for Patients With FGFR Alterations

By Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020 FEATURING Sarmad Sadeghi
By Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020 FEATURING Sarmad Sadeghi
254 views
February 26, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Updates in Oncology
20:17
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Overview of Immune Checkpoint Inhibitors in Gynecologic Cancers &…

Feat. O. Dorigo
14:01
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

The Future of Immunotherapy in Gynecologic Malignancies: Cell Therap…

Feat. O. Dorigo
11:13
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Therapeutic Efficacy of Vaccines & Tumor Immune Microenvironment…

Feat. O. Dorigo
24:44
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment of Metastatic Urothelial Carcinoma: Frontline Chemo, IO in…

Feat. S. Sadeghi
12:45
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

New Strategies for Metastatic Urothelial Carcinoma Treatment: Chemo …

Feat. S. Sadeghi
05:09
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Pembrolizumab for Patients with High-risk Non-Muscle-Invasive Bladde…

Feat. S. Sadeghi
29:02
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Are Cannabinoids Analgesics? Pain, the Endocannabinoid System, Canna…

Feat. P. Fine
09:08
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Are Cannabinoids Analgesics? Exogenous Cannabinoids and Cancer Pain,…

Feat. P. Fine
22:06
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Changes in Diet Can Have a Profound Impact on the Microbiome & D…

Feat. J. McQuade
11:46
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Medications and Microbiome: Antibiotics Associated With Worse Outcom…

Feat. J. McQuade
09:41
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment of Metastatic Colorectal Cancer & Sequencing Chemother…

Feat. J. Hecht
18:59
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Metastatic Colorectal Cancer Subtypes: Data on RAS Mutations, BRAF M…

Feat. J. Hecht
13:52
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

What the Sidedness Represent in mCRC, Consensus Molecular Subtypes &…

Feat. J. Hecht
22:57
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Stage III NSCLC: Can We Replace Chemotherapy With Immunotherapy?

Feat. J. Heymach
18:36
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Stage IV NSCLC: Should We Be Considering Local Consolidation Therapy…

Feat. J. Heymach